S&P 500   4,001.53 (+1.64%)
DOW   32,460.80 (+1.34%)
QQQ   313.68 (+2.47%)
AAPL   161.17 (+2.12%)
MSFT   280.35 (+2.96%)
META   206.76 (+3.48%)
GOOGL   105.87 (+2.42%)
AMZN   100.71 (+2.04%)
TSLA   197.19 (+3.16%)
NVDA   273.99 (+3.52%)
NIO   9.33 (+2.64%)
BABA   87.87 (+5.04%)
AMD   102.39 (+4.93%)
T   18.52 (+0.71%)
F   11.74 (+2.26%)
MU   61.05 (+4.95%)
CGC   1.92 (+2.13%)
GE   92.65 (+3.42%)
DIS   96.64 (+1.83%)
AMC   4.57 (+5.30%)
PFE   40.42 (+1.02%)
PYPL   74.46 (+0.16%)
NFLX   320.25 (+8.97%)
S&P 500   4,001.53 (+1.64%)
DOW   32,460.80 (+1.34%)
QQQ   313.68 (+2.47%)
AAPL   161.17 (+2.12%)
MSFT   280.35 (+2.96%)
META   206.76 (+3.48%)
GOOGL   105.87 (+2.42%)
AMZN   100.71 (+2.04%)
TSLA   197.19 (+3.16%)
NVDA   273.99 (+3.52%)
NIO   9.33 (+2.64%)
BABA   87.87 (+5.04%)
AMD   102.39 (+4.93%)
T   18.52 (+0.71%)
F   11.74 (+2.26%)
MU   61.05 (+4.95%)
CGC   1.92 (+2.13%)
GE   92.65 (+3.42%)
DIS   96.64 (+1.83%)
AMC   4.57 (+5.30%)
PFE   40.42 (+1.02%)
PYPL   74.46 (+0.16%)
NFLX   320.25 (+8.97%)
S&P 500   4,001.53 (+1.64%)
DOW   32,460.80 (+1.34%)
QQQ   313.68 (+2.47%)
AAPL   161.17 (+2.12%)
MSFT   280.35 (+2.96%)
META   206.76 (+3.48%)
GOOGL   105.87 (+2.42%)
AMZN   100.71 (+2.04%)
TSLA   197.19 (+3.16%)
NVDA   273.99 (+3.52%)
NIO   9.33 (+2.64%)
BABA   87.87 (+5.04%)
AMD   102.39 (+4.93%)
T   18.52 (+0.71%)
F   11.74 (+2.26%)
MU   61.05 (+4.95%)
CGC   1.92 (+2.13%)
GE   92.65 (+3.42%)
DIS   96.64 (+1.83%)
AMC   4.57 (+5.30%)
PFE   40.42 (+1.02%)
PYPL   74.46 (+0.16%)
NFLX   320.25 (+8.97%)
S&P 500   4,001.53 (+1.64%)
DOW   32,460.80 (+1.34%)
QQQ   313.68 (+2.47%)
AAPL   161.17 (+2.12%)
MSFT   280.35 (+2.96%)
META   206.76 (+3.48%)
GOOGL   105.87 (+2.42%)
AMZN   100.71 (+2.04%)
TSLA   197.19 (+3.16%)
NVDA   273.99 (+3.52%)
NIO   9.33 (+2.64%)
BABA   87.87 (+5.04%)
AMD   102.39 (+4.93%)
T   18.52 (+0.71%)
F   11.74 (+2.26%)
MU   61.05 (+4.95%)
CGC   1.92 (+2.13%)
GE   92.65 (+3.42%)
DIS   96.64 (+1.83%)
AMC   4.57 (+5.30%)
PFE   40.42 (+1.02%)
PYPL   74.46 (+0.16%)
NFLX   320.25 (+8.97%)
OTCMKTS:JCRRF

JCR Pharmaceuticals - JCRRF Stock Forecast, Price & News

$10.40
0.00 (0.00%)
(As of 03/22/2023 12:00 AM ET)
Add
Compare
Today's Range
$10.40
$10.40
50-Day Range
$10.40
$19.24
52-Week Range
$10.40
$12.38
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

JCRRF stock logo

About JCR Pharmaceuticals (OTCMKTS:JCRRF) Stock

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Receive JCRRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JCR Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

JCRRF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive JCRRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JCR Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - General
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:JCRRF
CIK
N/A
Fax
N/A
Employees
732
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Shin Ashida (Age 80)
    Chairman, CEO & Pres
  • Yoshihiro Ota
    Director of Accounting Department & Corp. Strategy Department (Fin.)
  • Yutaka Honda
    Sr. Corp. Officer,Exec. Director of Admin. Divs. & Director of Gen. Affairs Dept
  • Hiroyuki Fukuya
    Director of Legal Affairs Department - Admin. Division
  • Toru Ashida (Age 55)
    Sr. VP of Sales & Admin., Exec. Director of Sales Division and Director
  • Ryutaro Makino
    Director of Marketing Dept. & Group Mang. of Product Planning - Marketing Dept. for Sales Div.
  • Yoshiaki Ijiri
    Director of HR Planning Dept.
  • Katsuya Nishino (Age 67)
    Exec. VP
  • Tatsuo Suzuki Ph.D. (Age 69)
    MD, GM of Quality Assurance Division & Director of Regulatory Affairs
  • Hiroshi Yoshimoto (Age 72)
    Sr. Advisor













JCRRF Stock - Frequently Asked Questions

Should I buy or sell JCR Pharmaceuticals stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for JCR Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" JCRRF shares.
View JCRRF analyst ratings
or view top-rated stocks.

How have JCRRF shares performed in 2023?

JCR Pharmaceuticals' stock was trading at $19.24 at the beginning of 2023. Since then, JCRRF shares have decreased by 45.9% and is now trading at $10.40.
View the best growth stocks for 2023 here
.

Are investors shorting JCR Pharmaceuticals?

JCR Pharmaceuticals saw a decline in short interest in February. As of February 15th, there was short interest totaling 286,300 shares, a decline of 10.4% from the January 31st total of 319,700 shares. Based on an average daily volume of 200 shares, the short-interest ratio is currently 1,431.5 days.
View JCR Pharmaceuticals' Short Interest
.

What is JCR Pharmaceuticals' stock symbol?

JCR Pharmaceuticals trades on the OTCMKTS under the ticker symbol "JCRRF."

How do I buy shares of JCR Pharmaceuticals?

Shares of JCRRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is JCR Pharmaceuticals' stock price today?

One share of JCRRF stock can currently be purchased for approximately $10.40.

How many employees does JCR Pharmaceuticals have?

The company employs 732 workers across the globe.

How can I contact JCR Pharmaceuticals?

JCR Pharmaceuticals' mailing address is 3-19 Kasuga-cho, Ashiya, Hyogo 659-0021. The official website for the company is www.jcrpharm.co.jp. The company can be reached via phone at 81 7 9732 8591.

This page (OTCMKTS:JCRRF) was last updated on 3/23/2023 by MarketBeat.com Staff